Clinical Study of TS-143 in Healthy Adult Male Subjects (Multiple-Dose Administration)
Clinical trial NCT03595202 · COMPLETED
Trial details
- NCT number
- NCT03595202
- Sponsor
- Taisho Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-03
- Primary completion
- 2017-07-07
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.